Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
G
GNOM
Global X Genomics & Biotechnology ETF
49.3
2
USD
+0.39%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.39%
Monthly Change
+9.48%
6 month change
+6.52%
Year Change
+6.52%
Previous Close
49.1
3
Open
49.3
2
Low
49.3
2
High
49.3
2
Volume
5
Markets
US ETFs
GNOM
Open full chart
Full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
A
AZN
ASTRAZENECA PLC
1.2 M
5 706.0
2.3%
BEAM
Beam Therapeutics Inc
1.2 M
40.6 K
2.2%
TXG
10X Genomics Inc
1.1 M
49.1 K
2.2%
LEGN
Legend Biotech Corp
1.1 M
59.1 K
2.1%
RARE
Ultragenyx Pharmaceutical Inc
930.4 K
39.8 K
1.8%
WGS
GeneDx Holdings Corp
898.3 K
11.3 K
1.7%
WVE
WAVE Life Sciences Ltd
786.3 K
56.4 K
1.5%
Genscript Biotech Corp
761.6 K
498.9 K
1.5%
SRPT
SAREPTA THERAPEUTICS, INC.
686.8 K
41.0 K
1.3%
NTLA
INTELLIA THERAPEUTICS, INC.
621.1 K
45.1 K
1.2%
CDNA
CAREDX, INC.
418.5 K
22.3 K
0.8%
QURE
Uniqure NV
378.9 K
24.2 K
0.7%
VIR
Vir Biotechnology Inc
364.9 K
40.1 K
0.7%
PSNL
Personalis Inc
213.5 K
23.6 K
0.4%
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
200.8 K
119.5 K
0.4%
A
AGILENT TECHNOLOGIES, INC.
200.6 K
1 653.0
0.4%
RCKT
ROCKET PHARMACEUTICALS, INC.
188.2 K
37.6 K
0.4%
PRME
Prime Medicine Inc
187.9 K
40.7 K
0.4%
RGNX
Regenxbio Inc
185.2 K
20.5 K
0.4%
MYGN
MYRIAD GENETICS, INC.
180.9 K
39.2 K
0.3%
1
2
3
News
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
The Next Big Theme: May 2026
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
The Next Big Theme: April 2026
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil